Regeneron Pharmaceuticals
REGN
#354
Rank
ยฃ52.86 B
Marketcap
ยฃ504.29
Share price
0.45%
Change (1 day)
25.18%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: ยฃ52.86 Billion

As of July 2026 Regeneron Pharmaceuticals has a market cap of ยฃ52.86 Billion. This makes Regeneron Pharmaceuticals the world's 354th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ52.86 B-14.42%
2025ยฃ61.77 B-0.97%
2024ยฃ62.38 B-16.94%
2023ยฃ75.10 B15.65%
2022ยฃ64.94 B29.08%
2021ยฃ50.31 B33.04%
2020ยฃ37.81 B19.77%
2019ยฃ31.57 B-1.55%
2018ยฃ32.07 B7.32%
2017ยฃ29.88 B-4.75%
2016ยฃ31.37 B-18.15%
2015ยฃ38.33 B42.03%
2014ยฃ26.99 B62.26%
2013ยฃ16.63 B61.53%
2012ยฃ10.29 B211.91%
2011ยฃ3.30 B73.61%
2010ยฃ1.90 B56.92%
2009ยฃ1.21 B21.46%
2008ยฃ0.99 B4.09%
2007ยฃ0.95 B43.04%
2006ยฃ0.67 B28.77%
2005ยฃ0.52 B94.19%
2004ยฃ0.26 B-41.35%
2003ยฃ0.45 B-11.06%
2002ยฃ0.51 B-39.83%
2001ยฃ0.85 B-1.78%
2000ยฃ0.86 B250.62%
1999ยฃ0.24 B80.23%
1998ยฃ0.13 B-14.65%
1997ยฃ0.16 B-33.34%
1996ยฃ0.24 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

ยฃ52.86 Billion
by Nasdaq info icon info icon
ยฃ52.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ450.57 B 752.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ218.43 B 313.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ147.63 B 179.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ78.21 B 47.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ22.40 B-57.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ27.06 B-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA